Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development

Journal of Immunology

Volumn 171, Issue 8, 2003, Pages 4040-4047

  Gregori, Silvia ^a,b   Giarratana, Nadia ^a   Smiroldo, Simona ^a   Adorini, Luciano ^a  

^a BioXell SpA   (Italy)

^b SAN RAFFAELE SCIENTIFIC INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; CD4 ANTIGEN; GAMMA INTERFERON; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4;

AGE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIABETES MELLITUS; DISEASE COURSE; IMMUNOREGULATION; IMMUNOSTIMULATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PATHOGENESIS; PATHOGENICITY; PRIORITY JOURNAL; SPLEEN CELL; SUPPRESSOR CELL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TH1 CELL;

EID: 0141992907     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.8.4040     Document Type: Article

References (50)

1. Kikutani, H., and S. Makino. 1992. The murine autoimmune diabetes model: NOD and related strains. Adv. Immunol. 51:285.
2. Atkinson, M. A., and E. H. Leiter. 1999. The NOD mouse model of type 1 diabetes: as good as it getsr?. Nat. Med. 5:601.
3. Adorini, L., S, Gregori, and L. C. Harrison. 2002. Understanding autoimmune diabetes: insights from mouse models. Trends Mol. Med. 8:31.
4. Trembleau, S., G. Penna, E. Bosi, A. Mortara, M. K. Gately, and L. Adorini. 1995. IL-12 administration induces Th1 cells and accelerates autoimmune diabetes in NOD mice. J. Exp. Med. 181:817.
5. Benoist, C., and D. Mathis. 1997. Cell death mediators in autoimmune diabetes: no shortage of suspects. Cell 89:1.
6. Delovitch, T. L., and B. Singh. 1997, The non-obese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. Immunity 7:727.
7. Ridgway, W. M., M. Fasso, A. Lanctot, C. Garvey, and C. G. Fathman. 1996. Breaking self-tolerance in nonobese diabetic mice. J. Exp. Med. 183:1657.
8. Ymer, S. I., D. Huang, G. Penna, S. Gregori, K. Branson, L. Adorini, and G. Morahan. 2002. Polymorphisms in the II12b gene affect structure and expression of IL-12 in NOD and other autoimmune-prone mouse strains. Genes Immun. 3:151.
9. + immunoregulatory T cells that control autoimmune diabetes. Immunity 12:431.
10. Sakaguchi, S. 2000. Regulatory T cells: key controllers of immunologic self-tolerance. Cell 101:455.
11. + suppressor T cells: more questions than answers. Nat. Rev. Immunol. 2:389.
12. Sakaguchi, S., N. Sakaguchi. M. Asano, M. Itoh, and M. Toda. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155:1151.
13. + regulatory cells that control intestinal inflammation. J. Exp. Med. 192:295.
14. - subpopulations. J. Immunol. 165:3105.
15. + T cell levels in NOD mice. Proc. Natl. Acad. Sci. USA 99:12287.
16. Kukreja, A., G. Cost, J. Marker, C. Zhang, Z. Sun, K. Lin-Su, S. Ten, M. Sanz, M. Exley, B. Wilson. et al. 2002. Multiple immuno-regulatory defects in type-I diabetes. J. Clin. Invest. 109:131.
17. Andre, I., A. Gonzalez, B. Wang, J. Katz, C. Benoist, and D. Mathis. 1996. Checkpoints in the progression of autoimmune disease: lessons from diabetes models. Proc. Natl. Acad. Sci. USA 93:2260.
18. Jansen, A., F. Homo-Delarche, H. Hooijkaas, P. J. Leenen, M. Dardenne, and H. A. Drexhage. 1994. Immunohistological characterization of monocytes-macrophages and dendritic cells involved in the initiation of the insulitis and β cell destruction in NOD mice. Diabetes 43:667.
19. Hoglund, P., J. Mintern, C. Waltzinger, W. Heath, C. Benoist, and D. Mathis. 1999. Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes. J. Exp. Med. 189:331.
20. Hanninen, A., C. Taylor, P. R. Streeter, L. S. Stark, J. M. Sarte, J. A. Shizuru, O. Simell, and S. A. Michie. 1993. Vascular addressins are induced on islet vessels during insulitis in nonobese diabetic mice and are involved in lymphoid cell binding to islet endothelium. J. Clin. Invest. 92:2509.
21. Hasegawa, Y., K. Yokono, T. Taki, K. Amano, Y. Tominaga, R. Yoneda, N. Yagi, S. Maeda, H. Yagita, K. Okumura. et al. 1994. Prevention of autoimmune insulin-dependent diabetes in non-obese diabetic mice by anti-LFA-1 and anti-ICAM-1 mAb. Int. Immunol. 6:831.
22. 4. and L-selectin mediate T-cell homing to the pancreas in the model of adoptive transfer of diabetes in NOD mice. Diabetes 45:1181.
23. Balasa, B., A. La Cava, K. Van Gunst, L. Mocnik. D. Balakrishna, N. Nguyen, L. Tucker, and N. Sarvetnick. 2000. A mechanism for IL-10-mediated diabetes in the nonobese diabetic (NOD) mouse: ICAM-1 deficiency blocks accelerated diabetes. J. Immunol. 165:7330.
24. Martin, S., N. K. van den Engel, A. Vinke, E. Heidenthal, B. Schulte, and H. Kolb. 2001. Dominant role of intercellular adhesion molecule-1 in the pathogenesis of autoimmune diabetes in non-obese diabetic mice. J. Autoimmun. 17:109.
25. Trembleau, S., G. Penna, S. Gregori, M. K. Gately, and L. Adorini. 1997. Deviation of pancreas-infiltrating cells to Th2 by interleukin-12 antagonist administration inhibits autoimmune diabetes. Eur. J. Immunol. 27:2330.
26. Trembleau, S., G. Penna, S. Gregori, H. D. Chapman, D. V. Serreze, J. Magram, and L. Adorini. 1999. Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice. J. Immunol. 163:2960.
27. + T suppressor cell clones produce transforming growth factor β, but not interleukin 10, and are distinct from type 1 T regulatory cells. J. Exp. Med. 196:1335.
28. Abrams, J. S., M. G. Roncarolo, H. Yssel, U. Andersson, G. J. Gleich, and J. E. Silver. 1992. Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples. Immunol. Rev. 127:5.
29. + immunoregulatory T cells is antigen nonspecific. J. Immunol. 164:183.
30. Sprent, J., and C. D. Surh. 2002. T cell memory. Annu. Rev. Immunol. 20:551.
31. + regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J. Immunol. 169:4712.
32. Chirathaworn, C., J. E. Kohlmeier, S. A. Tibbetts, L. M. Rumsey, M. A. Chan, and S. H. Benedict. 2002. Stimulation through intercellular adhesion molecule-1 provides a second signal for T cell activation. J. Immunol. 168:5530.
33. + cells correlate with cytokine profiles in the spontaneously autoimmune diabetic mouse. Diabetes 45:71.
34. + thymocytes expressing L-selectin mediate "active tolerance" in the nonobese diabetic mouse. J. Immunol. 161:2620.
35. + T cells that prevent diabetes onset in nonobese diabetic mice. J. Immunol. 164:240.
36. + splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7. J. Immunol. 169:2461.
37. Bach, J. F., and L. Chatenoud. 2001. Tolerance to islet autoantigens in type 1 diabetes. Annu. Rev. Immunol. 19:131.
38. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188:287.
39. + naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J. Immunol. 162:5317.
40. Maloy, K., and F. Powrie. 2001. Regulatory T cells in the control of immune pathology. Nat. Immun. 2:816.
41. Asseman, C., S. Mauze, M. W. Leach, R. L. Coffman, and F. Powrie. 1999. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. 190:995.
42. Hara, M., C. I. Kingsley, M. Niimi, S. Read, S. E. Turvey, A. R. Bushell, P. J. Morris, F. Powrie, and K. J. Wood. 2001. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J. Immunol. 166:3789.
43. Balasa, B., K. Van Gunst, N. Jung, J. D. Katz, and N. Sarvetnick. 2000. IL-10 deficiency does not inhibit insulitis and accelerates cyclophosphamide-induced diabetes in the nonobese diabetic mouse. Cell. Immunol. 202:97.
44. Dougherty, G. J., S. Murdoch, and N. Hogg. 1988. The function of human intercellular adhesion molecule-1 (ICAM-1) in the generation of an immune response. Eur. J. Immunol. 18:35.
45. Dang, L. H., M. T. Michalek, F. Takei, B. Benaceraff, and K. L. Rock. 1990. Role of ICAM-1 in antigen presentation demonstrated by ICAM-1 defective mutants. J. Immunol. 144:4082.
46. Smits, H. H., E. C. de Jong, J. H. Schuitemaker, T. B. Geijtenbeek, Y. van Kooyk, M. L. Kapsenberg, and E. A. Wierenga. 2002. Intercellular adhesion molecule-1/LFA-1 ligation favors human Th1 development. J. Immunol. 168:1710.
47. Salomon, B., and J. A. Bluestone. 1998. LFA-1 interaction with ICAM-1 and ICAM-2 regulates Th2 cytokine production. J. Immunol. 161:5138.
48. Luksch, C. R., O. Winqvist, M. E. Ozaki, L. Karlsson, M. R. Jackson, P. A. Peterson, and S. R. Webb. 1999. Intercellular adhesion molecule-1 inhibits interleukin 4 production by naive T cells. Proc. Natl. Acad. Sci. USA 96:3023.
49. Camacho, S. A., W. R. Heath, F. R. Carbone, N. Sarvetnick, A. LeBon, L. Karlsson, P. A. Peterson, and S. R. Webb. 2001. A key role for ICAM-1 in generating effector cells mediating inflammatory responses. Nat. Immun. 2:523.
50. Chirathaworn, C., S. A. Tibbetts, M. A. Chan, and S. H. Benedict. 1995. Cross-linking of ICAM-1 on T cells induces transient tyrosine phosphorylation and inactivation of cdc2 kinase. J. Immunol. 155:5479.